Multicenter International Trial Ring AnnulopLasty (MITRAL)
This study has been completed.
Sponsor:
St. Jude Medical
Information provided by:
St. Jude Medical
ClinicalTrials.gov Identifier:
NCT00727012
First received: July 29, 2008
Last updated: July 12, 2011
Last verified: July 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This clinical study is a multicenter, prospective non-randomized observational study without concurrent or matched controls in which 150 patients receiving an SJM® Rigid Saddle Ring will be included. The primary objective of the study is to demonstrate the effectiveness of the SJM® Rigid Saddle Ring when used in mitral valve repair procedures.
| Condition | Intervention |
|---|---|
|
Mitral Valve Insufficiency |
Device: mitral valve repair (SJM® Rigid Saddle Ring) |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Multicenter International Trial Ring AnnulopLasty |
Further study details as provided by St. Jude Medical:
Primary Outcome Measures:
- Change in ERO (Effective Regurgitant Orifice) in cm2 calculated with PISA method at 6 months and at patient discharge compared to baseline (pre-operative). [ Time Frame: 6 months ] [ Designated as safety issue: No ]
- NYHA class [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- adverse events rates [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]
| Enrollment: | 180 |
| Study Start Date: | June 2008 |
| Study Completion Date: | November 2010 |
| Primary Completion Date: | November 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
SJM® Rigid Saddle Ring
The SJM® Rigid Saddle Ring is an annuloplasty ring comprised of a titanium core surrounded by a double-velour, polyester fabric sewing cuff.
|
Device: mitral valve repair (SJM® Rigid Saddle Ring)
mitral valve repair due to mitral degenerative or functional disease
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Patient requiring a mitral valve repair due to mitral degenerative or functional disease (Note: Patients that underwent concomitant procedures, e.g. coronary artery bypass grafting, are eligible for this study);
- Patient (or legal guardian) has signed a study specific informed consent form agreeing to the data collection and follow-up requirements;
- Patients are at least 18 years old.
Exclusion Criteria:
- Patient requires replacement of the aortic, tricuspid or pulmonary valve or has a pre-existing prosthetic valve;
- Patient is pregnant or nursing;
- Patient has active endocarditis;
- Patient is actively participating in another study of an investigational drug or device;
- Patients unavailable to follow-up visit (abroad residents, patients affected by neurological disorders...);
- Patients who are intravenous drug abusers, alcohol abusers, prison inmates or unable to give informed consent;
- Patients with a major non-cardiac evolving disease;
- Patients with a life expectancy less than 1 year;
- Patients are known to be noncompliant or are unlikely to complete the study;
- Any case in which mitral annuloplasty rings are not indicated;
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Prof. Dr. Raffaele De Simone, University of Heidelberg |
| ClinicalTrials.gov Identifier: | NCT00727012 History of Changes |
| Other Study ID Numbers: | CS06003RG |
| Study First Received: | July 29, 2008 |
| Last Updated: | July 12, 2011 |
| Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
Keywords provided by St. Jude Medical:
|
mitral valve heart valve valve repair |
valve disorder valve disease cardiac surgery |
Additional relevant MeSH terms:
|
Mitral Valve Insufficiency Heart Valve Diseases Heart Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 16, 2013